Funding Rounds
iOmx Therapeutics

iOmx Therapeutics Series B round, October 2021

iOmx Therapeutics

iOmx Therapeutics is a cancer Immunotherapy founded in 2016.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $75.26M

Raised Date: 2021-10-05

Investors